Literature DB >> 16473856

Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants.

R Varki1, S Sadowski, E Pfendner, J Uitto.   

Abstract

INTRODUCTION: Epidermolysis bullosa (EB), a group of autosomal heritable blistering diseases, is characterised by extensive phenotypic variability with considerable morbidity and mortality. EB is classified into distinct subtypes depending on the location of blistering within the cutaneous dermoepidermal basement membrane zone. Ten genes are known to harbour mutations in the major types of EB, and the level of expression of these genes within the cutaneous basement membrane zone and in extracutaneous tissues, as well as the types and combinations of the mutations, explain in general terms the phenotypic variability.
METHODS: The DebRA Molecular Diagnostics Laboratory, established in 1996 and supported in part by the patient advocacy organisation DebRA of America, has analysed over 1000 families with different forms of EB.
RESULTS: In total, 265 cases were submitted with the preliminary diagnosis of junctional or hemidesmosomal forms of EB. We found 393 mutant alleles in seven different genes, with 173 of the mutations being distinct and 71 previously unpublished. DISCUSSION: These findings attest to the clinical and molecular heterogeneity of the junctional and hemidesmosomal subtypes of EB. The results also reveal exceptions to the general rules on genotype-phenotype correlations, unusual phenotypes, and surprising genetics. Collectively, mutation analysis in different forms of EB provides the basis for improved classification with prognostic implications and for prenatal and preimplantation diagnosis in families at risk for recurrence of EB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473856      PMCID: PMC2564586          DOI: 10.1136/jmg.2005.039685

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  70 in total

Review 1.  Progress in epidermolysis bullosa: genetic classification and clinical implications.

Authors:  Jouni Uitto; Gabriele Richard
Journal:  Am J Med Genet C Semin Med Genet       Date:  2004-11-15       Impact factor: 3.908

2.  Hemidesmosomes: molecular organization and their importance for cell adhesion and disease.

Authors:  J Koster; L Borradori; A Sonnenberg
Journal:  Handb Exp Pharmacol       Date:  2004

Review 3.  Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes.

Authors:  L Pulkkinen; J Uitto
Journal:  Exp Dermatol       Date:  1998 Apr-Jun       Impact factor: 3.960

4.  Pyloric atresia-junctional epidermolysis bullosa syndrome: mutations in the integrin beta4 gene (ITGB4) in two unrelated patients with mild disease.

Authors:  J E Mellerio; L Pulkkinen; J R McMillan; B D Lake; H M Horn; M J Tidman; J I Harper; J A McGrath; J Uitto; R A Eady
Journal:  Br J Dermatol       Date:  1998-11       Impact factor: 9.302

5.  Combination of a novel frameshift mutation (1929delCA) and a recurrent nonsense mutation (W610X) of the LAMB3 gene in a Japanese patient with Herlitz junctional epidermolysis bullosa, and their application for prenatal testing.

Authors:  Y Takizawa; H Shimizu; L Pulkkinen; K Suzumori; H Kakinuma; J Uitto; T Nishikawa
Journal:  J Invest Dermatol       Date:  1998-12       Impact factor: 8.551

6.  Detection of sequence variants in the gene encoding the beta 3 chain of laminin 5 (LAMB3).

Authors:  L Pulkkinen; J A McGrath; A M Christiano; J Uitto
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

7.  Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition.

Authors:  J A McGrath; B Gatalica; K Li; M G Dunnill; J R McMillan; A M Christiano; R A Eady; J Uitto
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

8.  Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa.

Authors:  T N Darling; J A McGrath; C Yee; B Gatalica; R Hametner; J W Bauer; G Pohla-Gubo; A M Christiano; J Uitto; H Hintner; K B Yancey
Journal:  J Invest Dermatol       Date:  1997-04       Impact factor: 8.551

9.  Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense.

Authors:  L Pulkkinen; F Rouan; L Bruckner-Tuderman; R Wallerstein; M Garzon; T Brown; L Smith; W Carter; J Uitto
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

10.  Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa.

Authors:  Patrizia Posteraro; Naomi De Luca; Guerrino Meneguzzi; May El Hachem; Corrado Angelo; Tommaso Gobello; Gianluca Tadini; Giovanna Zambruno; Daniele Castiglia
Journal:  J Invest Dermatol       Date:  2004-10       Impact factor: 8.551

View more
  33 in total

1.  A direct method to determine the strength of the dermal-epidermal junction in a mouse model for epidermolysis bullosa.

Authors:  Thomas J Sproule; Derry C Roopenian; John P Sundberg
Journal:  Exp Dermatol       Date:  2012-04-16       Impact factor: 3.960

2.  First successful preimplantation genetic diagnosis of epidermolysis bullosa with pyloric atresia: case study of a novel c.4505-4508insACTC mutation.

Authors:  Ayvaz Ozge; Hatırnaz Safak; Hatırnaz Ebru; Unsal Evrim; Sinanoglu Ekin Bilge; Ozer Leyla; Kadı Ali Kemal; Baltacı Volkan
Journal:  J Assist Reprod Genet       Date:  2012-02-22       Impact factor: 3.412

3.  Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.

Authors:  Roslyn Varki; Sara Sadowski; Jouni Uitto; Ellen Pfendner
Journal:  J Med Genet       Date:  2006-09-13       Impact factor: 6.318

Review 4.  Diseases of epidermal keratins and their linker proteins.

Authors:  Jouni Uitto; Gabriele Richard; John A McGrath
Journal:  Exp Cell Res       Date:  2007-04-24       Impact factor: 3.905

Review 5.  Bridging structure with function: structural, regulatory, and developmental role of laminins.

Authors:  Julia Tzu; M Peter Marinkovich
Journal:  Int J Biochem Cell Biol       Date:  2007-08-06       Impact factor: 5.085

6.  Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro.

Authors:  Olga Igoucheva; Aislinn Kelly; Jouni Uitto; Vitali Alexeev
Journal:  J Invest Dermatol       Date:  2007-12-13       Impact factor: 8.551

Review 7.  [Epidermolysis bullosa. An update].

Authors:  H Schumann
Journal:  Hautarzt       Date:  2009-08       Impact factor: 0.751

Review 8.  Regulation of dental enamel shape and hardness.

Authors:  J P Simmer; P Papagerakis; C E Smith; D C Fisher; A N Rountrey; L Zheng; J C C Hu
Journal:  J Dent Res       Date:  2010-07-30       Impact factor: 6.116

9.  Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.

Authors:  Anna M G Pasmooij; Hendri H Pas; Maria C Bolling; Marcel F Jonkman
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 10.  Epidermolysis bullosa with pyloric atresia.

Authors:  Hye Jin Chung; Jouni Uitto
Journal:  Dermatol Clin       Date:  2010-01       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.